CTI BioPharma Corp. (NASDAQ:CTIC) traded 2.15 Million shares and was closed at $5.78 per share. The current share price indicates that stock is 6.45% away from its one year high and is moving 2199.13% ahead of its …
CTI BioPharma
The Company expects to start the trial in Q2 2017. Register for free on Stock-Callers.com and download the …
Arena Pharmaceuticals
Recently, investment analysts covering the stock have updated the mean …
NASDAQ
This is a technical analysis stock rating for CTI BioPharma Corp. (NASDAQ:CTIC) . The company has a four bull technical rating which indicates some strength. The risk here is a potentially overbought situation, but for now, …
On a numerical scale from 1 to 5, a rating of 1 or 2 would ... Stock Reaching Most Volatile List Today: CTI BioPharma Corp. (NASDAQ:CTIC) - Wall Street Beacon January 11, 2017 - Shares of CTI BioPharma Corp. …
Stock Market
The stock market indices started the week off in a very strange ... Checking TheTechTrader.com percent-gain leaderboard, CTI BioPharma Corp. (CTIC) popped 98 cents, or 20%, to 5.78, on 2.1 million shares traded. …
Nasdaq
CTI BioPharma Corp (NASDAQ:CTIC) announced positive progress on its lead programs in addition to key …
Shares of CTI BioPharma Corp. (NASDAQ:CTIC) slipped more than 10% in trade today after the company issued a press release yesterday, in which it announced it will put up its Series 21 Preferred Stock in an underwritten …
CTI Biopharma (NASDAQ: CTIC) CTIC has had a very interesting time in the market this week. After presenting data from its study known as PERSIST-1 at the ASCO 2015 presentation, the company's stock climbed …